Return to Special Authority drug list
Generic name |
vancomycin |
---|---|
Strength & form |
125 mg, 250 mg capsule |
Special Authority criteria |
Approval period |
---|---|
For the treatment of symptomatic clostridium difficile infection (CDI), when: The patient is allergic, resistant or intolerant to metronidazole OR The patient has failed to respond to 4 to 6 days of oral metronidazole at doses of 500 mg three times per day OR The patient has symptoms of moderate to severe disease or is experiencing a second disease recurrencei OR The patient was initiated on vancomycin as an inpatient (e.g., in a hospital setting, nursing home, or long-term care facility) and requires continuation of vancomycin to complete their full course of therapy |
Initial: up to 14 days Second or further recurrence: up to 14 days |